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Abstract: The combination of biocatalysis and chemo-catal-
ysis increasingly offers chemists access to more diverse
chemical architectures. Here, we describe the combination of
a toolbox of chiral-amine-producing biocatalysts with a Buch-
wald–Hartwig cross-coupling reaction, affording a variety of
a-chiral aniline derivatives. The use of a surfactant allowed
reactions to be performed sequentially in the same flask,
preventing the palladium catalyst from being inhibited by the
high concentrations of ammonia, salts, or buffers present in the
aqueous media in most cases. The methodology was further
extended by combining with a dual-enzyme biocatalytic
hydrogen-borrowing cascade in one pot to allow for the
conversion of a racemic alcohol to a chiral aniline.
N-arylamines are an important structural motif present in
an array of bioactive molecules including APIs and agro-
chemicals (Figure 1). Methods for the synthesis of these
compounds in enantiomerically enriched form, that are
typically based on asymmetric reductive aminations of
ketones using anilines as the amine donor, are well
known.[1] Transition metal catalysed reductive amination
often requires elevated temperatures and pressures in addi-
tion to complex chiral ligands to achieve satisfactory yields
and enantiomeric excess (ee).[2–5] On the other hand, organo-
catalytic approaches require anhydrous conditions in order to
proceed however excellent yield and ee can be obtained under
relatively mild conditions.[6–8]
Biocatalysis represents a powerful tool for the synthesis of
enantiomerically pure chiral amines.[9] Several different
enzyme classes have been reported including amine dehy-
drogenases (AmDH),[10, 11] imine reductases (IRED) and
reductive aminases (RedAm),[12–14] amine oxidases
(MAO),[15, 16] w-transaminases (w-TA),[17, 18] and engineered
cytochrome P411s.[19,20] Despite the broad application of these
biocatalysts for the synthesis of both cyclic and acyclic 18, 28
and 38 amines, there have been few reports describing the
application of these systems for the synthesis of N-aryl
amines.[15, 21, 22] Interestingly, two recent papers reported
homologues of AspRedAm that accepted aniline as amine
donor with conversions up to 99%, however the substrate
scope was limited.[23, 24]
The combination of biocatalysts and chemo-catalysts
allows chemists to effect overall transformations with high
efficiency, not achievable using the individual catalysts
alone.[25–28] Several strategies for merging precious-metal
catalysis and biocatalysis have been reported.[29–34] In partic-
ular, palladium catalysed methods have featured in several
reported chemoenzymatic reactions, with biocatalytic pro-
cesses coupled to Suzuki–Miyaura[35] and Heck[36] cross-
coupling or Wacker[37] oxidation. One frequently used Pd-
catalysed transformation yet to be combined with biocatalysis
is the Buchwald-Hartwig cross-coupling (BHA), which cou-
ples nucleophilic amines and aryl halides to afford ani-
lines.[38–41]
Herein we present a chemoenzymatic approach to chiral
N-arylamines, combining a variety of enantioselective bio-
catalytic transformations with a surfactant-enabled BHA
(Scheme 1).[11,40, 42]
Figure 1. High-value chiral N-arylamine derivatives.
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We initially envisaged a one-pot process involving con-
version of the substrate (ketone/imine/alcohol) followed by in
situ BHA in an aqueous environment without any intermedi-
ate workup. In line with the principles of green chemistry
there is significant interest in performing transition metal
catalysed reactions in water.[43] For example, the use of water-
soluble palladium sources in the Suzuki cross-coupling
combined with an alcohol dehydrogenase (ADH) reported
by Borchert et al. , gave excellent yields and ee but is limited
to water soluble starting materials.[33] Other approaches using
heterogeneous, immobilised or compartmentalised catalysts
have also been described.[29, 34]
One plausible reason for the limited number of one-pot
chemo-enzymatic processes reported is the low solubility of
many organic reagents in water,[44] leading to slow reaction
rates and low yields. The Lipshutz group have reported
a designer surfactant DL-a-tocopherol methoxypolyethylene
glycol succinate (TPGS-750-M, Figure 2) that enables a vari-
ety of important cross-coupling reactions to proceed in
water.[45–47] Owing to the relatively low concentration of the
surfactant, reactants are highly concentrated within the
lipophilic core. Rate acceleration, even at room temperature,
is commonly observed as a result. The Lipshutz group
demonstrated recently that TPGS-750-M could be used in
one-pot, chemo-enzymatic transformations using several pre-
cious-metal catalysts and ADH enzymes.[48] They showed Pd
could be used in conjunction with ADH as well, however the
biotransformation mixture was added after the metal-cata-
lysed step was complete.
From the outset, it was unknown if either the enzyme or
any component of the biotransformation mixture would be
detrimental to the performance of the cross-coupling step.
Initially we chose to use engineered amine dehydrogenases
(AmDHs), which use ammonia as the sole amine source.[10,42]
AmDHs have also been applied in an elegant redox-neutral
cascade alongside ADHs for the asymmetric amination of
alcohols.[49–52] Hence, there is also an opportunity to generate
optically enriched N-arylamines from racemic alcohols.
Initially we screened a number of palladium pre-catalysts,
ligands and conditions to promote the coupling of model
substrate rac-1 with bromobenzene 2a (Table 1).[45,53, 54] To
Scheme 1. Retrosynthetic strategies for the chemoenzymatic formation
of chiral N-arylamines.
Figure 2. Structural components of TPGS-750-M.
Table 1: Optimisation of Buchwald-Hartwig amination under biocatalyst conditions.
Entry T Solvent Pd-cat Ligand Additive Conv. [%][a]
1 100 water [PdCl(cinnamyl)]2 CyJohnPhos n.a. 6
2 100 1m NH4Cl [PdCl(cinnamyl)]2 CyJohnPhos n.a. 0
3 room temp. water [PdCl(allyl)]2 cBRIDP TPGS-750-M 57 (24 h)
4 room temp. 1m NH4Cl [PdCl(allyl)]2 cBRIDP TPGS-750-M 26
5 40 1m NH4Cl [PdCl(allyl)]2 cBRIDP TPGS-750-M >99
6 40 1m NH4Cl +CFE [PdCl(allyl)]2 cBRIDP TPGS-750-M 9
7 40 1m NH4Cl+ filtered CFE [PdCl(allyl)]2 cBRIDP TPGS-750-M 23
8 room temp. water [PdCl(allyl)]2 tBuXPhos TPGS-750-M 0
9 50 water [PdCl(allyl)]2 tBuXPhos TPGS-750-M >99
10 50 1m NH4Cl [PdCl(allyl)]2 tBuXPhos TPGS-750-M >99
11 50 1m NH4Cl+ CFE [PdCl(allyl)]2 tBuXPhos TPGS-750-M 80
12 50 1m NH4Cl+ filtered CFE [PdCl(allyl)]2 tBuXPhos TPGS-750-M 95
13 50 1m NH4Cl+ purified enzyme [PdCl(allyl)]2 tBuXPhos TPGS-750-M 90
[a] Conversion determined by GC-FID analysis.
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investigate any potential inhibitory effects, the cross-coupling
conditions were screened in the presence of reagents required
for the biocatalytic step. The impact of different biocatalyst
preparations (cell free extract (CFE) or purified proteins),
and the presence of high concentrations of ammonium salts
were thus investigated.
The ligand tBuXPhos, has been reported to be a general
ligand suited to the coupling of primary amines,[54] and in
combination with the [PdCl(allyl)]2 pre-catalyst reliably gave
the best conversions in the absence of the biocatalyst.
Importantly, the addition of concentrated ammonium chlo-
ride (necessary for the AmDH step) did not affect the
outcome of the cross-coupling (entry 10). Finally, it was noted
that in the presence of the CFE containing the biocatalyst
(entry 11) the conversions were lower than with filtered CFE
(entry 12). However, in the presence of the purified enzymes
the conversions were good to excellent (90 %) (entry 13).
Encouraged that the chemoenzymatic process could be
combined efficiently in a one-pot, two-step process, the
reductive amination of ketones 4 and 7 (50 mm) to afford
amines (R)-1 and (R)-5 (90 % conversion, 90% and> 99 % ee,
respectively) was performed using previously optimised
conditions for AmDH biotransformations.[55] The crude
reaction mixture was diluted 1:1 with a solution of TPGS-
750-M (5 wt % in H2O) followed by addition of the reagents
for the cross-coupling step (Scheme 2).
The coupling of amines (R)-1 and (R)-5 with a panel of
aryl bromides 2a–g was accomplished using the optimised
conditions for the cross-coupling step to yield N-arylamines
3a–g and 6a–g with good to excellent conversions (Table 2).
Importantly, the chirality generated during the biocatalytic
step was preserved during the cross-coupling step (see
Supporting Information).
We next considered a one-pot N-arylation reaction in
which the chiral amine was generated by an w-transaminase
(w-TA).[17] w-TAs are attractive options for the first step since
they possess broad substrate scope and give excellent ees.[17,18]
The transamination of ketone 4 (50 mm) with ATA-117
(Codexis, USA) gave (R)-1 (> 99% conversion, > 99% ee)
using an excess of alanine as the amine donor. However, when
the one-pot N-arylation of 1 with 2a was attempted, no
coupling was observed, presumably due to the presence of the
competing nucleophilic amine alanine. Instead, the reaction
mixture from the biotransformation containing (R)-1 was
extracted into toluene and then coupling of (R)-1 with 2a–c
and 2 f,g could be performed under reported conditions to
give 3 a–c and 3 f,g (63–99 % conversion and > 99% ee) (see
Supporting Information).
To further exemplify the scope of our combined chemo-
enzymatic approach, we envisaged extending the process to
the N-arylation of cyclic chiral amines to furnish tertiary N-
arylamines. Imine reductases (IREDs) have been reported for
the reduction of cyclic imines,[22] amongst which the (S)-imine
reductase (S-IRED) from Streptomyces sp. GF3546 is
reported to catalyse the asymmetric reduction of cyclic five-,
six-, and seven-membered imines.[12, 56]
The S-IRED catalysed asymmetric reduction of pyrroline
8 was performed under previously reported conditions to
afford (S)-2-methylpyrrolidine 9 (80 % conv. > 92% ee). The
reaction mixture was then diluted with a solution of TPGS-
750-M as described above. Using the Takasago ligand
cBRIDP in lieu of tBuXPhos[57] gave efficient coupling with
aryl bromides 2a–g to the corresponding N-arylamines 10a–g
with good to excellent conversions (Table 3). To demonstrate
the synthetic utility of this method, 10 a was prepared on
a preparative scale with the addition of a toluene layer for the
BHA, affording > 100 mg in a 65% isolated yield and > 99%
ee (see Supporting Information).
Lastly, the same methodology was shown to be compatible
with the recently developed biocatalytic hydrogen-borrowing
amination of alcohols.[52] The system employs a non-enantio-
selective variant (W110A-G198D) of an alcohol dehydrogen-
ase from Thermoanaerobacter ethanolicus coupled with
ChiAmDH (Scheme 3). On a preparative scale the chiral N-
arylamine 6c was obtained directly from the racemic alcohol
11 with moderate yield and > 99 % ee. The modest isolated
yield of (R)-6c can be ascribed to some of the limitations of
this methodology, namely: (i) the challenge of extraction and
Scheme 2. Combined AmDH amination with BHA of ketones 4 and 7.
Table 2: Conversions for N-arylation of amines (R)-1 and (R)-5 with aryl
bromides 2a-g.
Product Conv. (%)[a,b] Product Conv. (%)[a,b]
3a 90 (81) 6a 90 (81)
3b 71 (64) 6b 65 (59)
3c 93 (83) 6c 82 (74)
3d 91 (82) 6d 81 (73)
3e 62 (56) 6e 59[c] (53)
3 f 70 (63) 6 f 54 (49)
3g 76 (68) 6g 90 (81)
[a] Conversion determined by GC-FID analysis. [b] Conversion for
Buchwald-Hartwig step indicated out of brackets, with overall conversion
from ketone to aniline indicated in brackets. [c] Oxidation to the
corresponding aromatic aldehyde was observed.
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purification of products from a surfactant-containing mixture,
and (ii) the equilibrium-based limitations to the conversion to
the amine. Both issues could be addressed in the future
through reaction engineering, for example in situ product
removal could be applied to shift the equilibrium of the
reaction, or crystallization could be used to improve isolation
of products from the complex reaction mixture.
In summary, we have demonstrated a new approach to the
synthesis of chiral N-arylamines by combining biocatalytic
reductive amination or imine reduction with surfactant-
enabled Buchwald-Hartwig cross-coupling. Conversions to
the corresponding N-arylated amines are good to excellent
(up to 90 %). Importantly, the asymmetric centre established
in the biocatalytic step is unaffected by the subsequent cross-
coupling reaction.
We envisage that this biocompatible, surfactant-enabled
cross-coupling approach will broaden the application of
chemo-enzymatic processes for the synthesis of high-value
compounds.
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